Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (81-90 of 602) with videos related to

Pageof 61
Sort By:
Current Opinion in Neurobiology|December 17, 2025
Context matters: Conflicting roles of interferon-γ signaling in CNS diseasesJonathan Nulman, Jason D Ulrich, David M Holtzman
Molecular Neurodegeneration|December 22, 2018
New insights into the role of TREM2 in Alzheimer's diseaseMaud Gratuze, Cheryl E G Leyns, David M Holtzman
The Lancet. Neurology|February 26, 2011
Apolipoprotein E in Alzheimer's disease and other neurological disordersPhilip B Verghese, Joseph M Castellano, David M Holtzman
Science Translational Medicine|April 8, 2011
Alzheimer's disease: the challenge of the second centuryDavid M Holtzman, John C Morris, Alison M Goate
Neurobiology of Aging|September 3, 2008
Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's diseaseHua Cheng, Yunhua Zhou, David M Holtzman, et al.
Experimental & Molecular Medicine|March 14, 2015
Sleep, circadian rhythms, and the pathogenesis of Alzheimer diseaseErik S Musiek, David D Xiong, David M Holtzman
Neuron|October 24, 2015
Re-evaluation of the Blood-Brain Barrier in the Presence of Alzheimer's Disease PathologyJason D Ulrich, Tien-Phat Huynh, David M Holtzman
Nature|October 16, 2009
Multimodal techniques for diagnosis and prognosis of Alzheimer's diseaseRichard J Perrin, Anne M Fagan, David M Holtzman
Cell Research|September 7, 2019
The microbiome: A target for Alzheimer disease?Dong-Oh Seo, Benjamin D Boros, David M Holtzman
Neurobiology of Disease|November 18, 2008
Biomarkers of Alzheimer's diseaseRebecca Craig-Schapiro, Anne M Fagan, David M Holtzman
Pageof 61

Showing results (81-90 of 602) with videos related to

Sort By:
Pageof 61
Current Opinion in Neurobiology|December 17, 2025
Context matters: Conflicting roles of interferon-γ signaling in CNS diseasesJonathan Nulman, Jason D Ulrich, David M Holtzman
Molecular Neurodegeneration|December 22, 2018
New insights into the role of TREM2 in Alzheimer's diseaseMaud Gratuze, Cheryl E G Leyns, David M Holtzman
The Lancet. Neurology|February 26, 2011
Apolipoprotein E in Alzheimer's disease and other neurological disordersPhilip B Verghese, Joseph M Castellano, David M Holtzman
Science Translational Medicine|April 8, 2011
Alzheimer's disease: the challenge of the second centuryDavid M Holtzman, John C Morris, Alison M Goate
Neurobiology of Aging|September 3, 2008
Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's diseaseHua Cheng, Yunhua Zhou, David M Holtzman, et al.
Experimental & Molecular Medicine|March 14, 2015
Sleep, circadian rhythms, and the pathogenesis of Alzheimer diseaseErik S Musiek, David D Xiong, David M Holtzman
Neuron|October 24, 2015
Re-evaluation of the Blood-Brain Barrier in the Presence of Alzheimer's Disease PathologyJason D Ulrich, Tien-Phat Huynh, David M Holtzman
Nature|October 16, 2009
Multimodal techniques for diagnosis and prognosis of Alzheimer's diseaseRichard J Perrin, Anne M Fagan, David M Holtzman
Cell Research|September 7, 2019
The microbiome: A target for Alzheimer disease?Dong-Oh Seo, Benjamin D Boros, David M Holtzman
Neurobiology of Disease|November 18, 2008
Biomarkers of Alzheimer's diseaseRebecca Craig-Schapiro, Anne M Fagan, David M Holtzman
Pageof 61